# Optimal Evaluation to Reduce Cardiovascular Imaging Testing

> **NCT05640752** · NA · RECRUITING · sponsor: **Tianjin Chest Hospital** · enrollment: 800 (estimated)

## Conditions studied

- Chronic Coronary Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** 2019 ESC guideline-determined diagnostic strategy
- **DIAGNOSTIC_TEST:** 2016 NICE guideline-determined diagnostic strategy

## Key facts

- **NCT ID:** NCT05640752
- **Lead sponsor:** Tianjin Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-11
- **Primary completion:** 2024-12-11
- **Final completion:** 2025-12-11
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05640752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05640752, "Optimal Evaluation to Reduce Cardiovascular Imaging Testing". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05640752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*